Mark Milley, the former chair of the Joint Chiefs of Staff, will give the retired ... former director of the National Institute of Allergy and Infectious Diseases; some of Biden’s family members; and members of the House committee that investigated ...

US President Joe Biden has issued preemptive pardons for former Chairman of the Joint Chiefs of Staff General Mark Milley, Dr. Anthony Fauci, and mem

Milley, who served as chairman of the Joint Chiefs of Staff during ... Fauci, who served as director of the National Institute of Allergy and Infectious Diseases for nearly four decades, became ...

Gen. Mark Milley, the now-retired former chairman of the Joint Chiefs of Staff, commented on the pardon he received in Biden's final hours in office.

The president has denied protection to four men he put in mortal danger.

The heads of the Jan_ 6 committee say they're grateful for the decision by President Joe Biden to pardon them “not for breaking the law but for upholding it.”

Biden’s Fauci pardon was greeted by many in the vast and chaotic world of Covid suspicion as proof the scientist and retired public health official had been guilty of some poorly-defined crime all along. It also demonstrated how closely mainstream Republicans are aligned with the deepest reaches of the Covid conspiracy pool.

In his address, Trump confirmed his plans to sign a series of executive orders on Day One, including declaring a national emergency at the U.S.-Mexico border, shutting down "illegal entry," and beginning "the process of returning millions and millions of criminal aliens back to the places from which they came.

Just before leaving office on 24 January, President Joe Biden announced a pre-emptive pardon for Anthony Fauci and other high ranking officials, forgiving them for any misdeeds they might have committed.

President Trump’s decision to pull out of the international health agency could deprive the United States of crucial scientific data and lessen the country’s influence in setting a global health agenda.

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.